{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:52Z","timestamp":1786995472764,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pbb.2025.174117","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:13:33Z","timestamp":1761300813000},"page":"174117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dual orexin receptor antagonists in insomnia: Toward a new therapeutic paradigm"],"prefix":"10.1016","volume":"258","author":[{"given":"Shigeyuki","family":"Chaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Imadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2025.174117_bb0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","article-title":"Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia","volume":"37","author":"Bettica","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2025.174117_bb0010","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00213-025-06767-1","article-title":"Orexin receptors: possible therapeutic targets for psychiatric disorders","volume":"242","author":"Chaki","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174117_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.109.152009","article-title":"Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat","volume":"330","author":"Dugovic","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174117_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115489","article-title":"Discovery of ORN0829, a potent dual orexin 1\/2 receptor antagonist for the treatment of insomnia","volume":"28","author":"Futamura","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbb.2025.174117_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2025.174117_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103624","article-title":"Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonist","volume":"392","author":"Hikichi","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174117_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hup.282","article-title":"Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening","volume":"16","author":"Hindmarch","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174117_bb0040","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00382B","article-title":"Syntheses and preclinical evaluations of 11C-labeled radioligands for imaging brain orexin-1 and orexin-2 receptors with positron emission tomography","author":"Jana","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.pbb.2025.174117_bb0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bcpt.13930","article-title":"Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant\/TS-142 in healthy Japanese participants following single\/multiple dosing: randomized, double-blind, placebo-controlled phase-1 studies","volume":"133","author":"Kambe","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2025.174117_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174117_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41398-025-03439-8","article-title":"Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis","volume":"15","author":"Kishi","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174117_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174117_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/sleep\/22.1.33","article-title":"Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists","volume":"22","author":"Lancel","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.pbb.2025.174117_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/cpdd.817","article-title":"Pharmacokinetics, pharmacodynamics, and safety of the dual orexin receptor antagonist lemborexant: findings from single-dose and multiple-ascending-dose phase 1 studies in healthy adults","volume":"10","author":"Landry","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.pbb.2025.174117_bb0075","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41380-024-02846-5","article-title":"Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"30","author":"Mesens","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174117_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/NSS.S201994","article-title":"Targeting orexin receptors for the treatment of insomnia: from physiological mechanisms to current clinical evidence and recommendations","volume":"15","author":"Mogavero","year":"2023","journal-title":"Nat. Sci. Sleep."},{"key":"10.1016\/j.pbb.2025.174117_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039131","article-title":"Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone","volume":"7","author":"Morairty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174117_bb0090","author":"MSD Inc"},{"key":"10.1016\/j.pbb.2025.174117_bb0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cpt.1046","article-title":"Accelerated development of the dual orexin receptor antagonist ACT-541468: integration of a microtracer in a first-in-human study","volume":"104","author":"Muehlan","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2025.174117_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13902","article-title":"The orexin story and orexin receptor antagonists for the treatment of insomnia","volume":"32","author":"Muehlan","year":"2023","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.pbb.2025.174117_bb0105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(22)00879-0","article-title":"Insomnia","volume":"400","author":"Perlis","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2025.174117_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13604","article-title":"Insomnia disorder: state of the science and challenges for the future","volume":"31","author":"Riemann","year":"2022","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.pbb.2025.174117_bb0115","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ijnp\/pyab050","article-title":"Efficacy and safety of seltorexant as adjunctive therapy in major depressive disorder: a phase 2b, randomized, placebo-controlled, adaptive dose-finding study","volume":"24","author":"Savitz","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2025.174117_bb0120","doi-asserted-by":"crossref","first-page":"20260","DOI":"10.1073\/pnas.1320325110","article-title":"Orexin\/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus","volume":"110","author":"Sears","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbb.2025.174117_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/jpet.117.241596","article-title":"The use of physiology-based pharmacokinetic and pharmacodynamic modeling in the discovery of the dual orexin receptor antagonist ACT-541468","volume":"362","author":"Treiber","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174117_bb0130","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00213-022-06089-6","article-title":"Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study","volume":"239","author":"Uchiyama","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174117_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2017.00083","article-title":"Selective inhibition of orexin-2 receptors prevents stress-induced ACTH release in mice","volume":"11","author":"Yun","year":"2017","journal-title":"Front. Behav. Neurosci."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:52:15Z","timestamp":1781067135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S0091305725001649"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174117","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual orexin receptor antagonists in insomnia: Toward a new therapeutic paradigm","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"174117"}}